Stock Details
ABT is Abbott Laboratories's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 111.36$. Average daily volumn in 3 months 5.44M. Market cap 190.31B



Stock symbol : ABT. Exchange : NYSE. Currency : USD
Lastest price : 108.69$. Total volume : 3.85M. Market state PRE
Click reload if you want to check the lastest price on market!!!

Abbott Laboratories (ABT)
Last Price
108.69$
Change
-0.61
Volume
3.85M

Previous Close109.30
Open108.83
Day Range108.13-109.50
Bid108.15 x 900
Ask109.69 x 900
Volume3.85M
Average Volume5.44M
Market Cap190.31B
Beta0.74
52 Week Range101.24-142.60
Trailing P/E25.22
Foward P/E22.32
Dividend (Yield %)1.73%
Ex-Dividend Date2022-07-14



Financial Details


According to Abbott Laboratories's financial reports the company's revenue in 2021 were 43.08B an increase( +26.47%) over the years 2020 revenue that were of 34.61B. In 2021 the company's total earnings were 7.07B while total earnings in 2020 were 4.5B( +75%).


Loading ...



Organization

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecologi... cal disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Mรฉniรจre's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Market Cap:
190.31B
Revenue:
43.08B
Total Assets:
75.2B
Total Cash:
9.8B


News about "Abbott Laboratories"

abbott-laboratories-nyseabt-stock-position-decreased-by-ipswich-investment-management-co-inc-image

Abbott Laboratories (NYSE:ABT) Stock Position Decreased by Ipswich Investment Management Co. Inc.

Source from : Defense World - 1 days ago

Ipswich Investment Management Co. Inc. cut its position in shares of Abbott Laboratories (NYSE:ABT โ€“ Get Rating) by 0.6% in the first quarter, according to its most recent 13F filing with the ...See details»


abbott-laboratories-nyseabt-stake-cut-by-ipswich-investment-management-co-inc-image

Abbott Laboratories (NYSE:ABT) Stake Cut by Ipswich Investment Management Co. Inc.

Source from : Defense World - 1 days ago

Ipswich Investment Management Co. Inc. reduced its holdings in Abbott Laboratories (NYSE:ABT โ€“ Get Rating) by 0.6% in the 1st quarter, according to the company in its most recent 13F filing with the ...See details»


abbott-successfully-handled-the-infant-formula-crisis-image

Abbott: Successfully Handled The Infant Formula Crisis

Source from : Seeking Alpha - 3 days ago

Abbott (ABT) was caught in a middle of the infant formula crisis. Read this article to know why I think ABT stock may bounce back over the next year.See details»


fda-investigates-new-report-of-another-babys-death-possibly-tied-to-abbott-formula-image

FDA investigates new report of another babyโ€™s death possibly tied to Abbott formula

Source from : WJBK - 14 days ago

The FDA has reviewed dozens of complaints involving Abbott formula after the company voluntarily recalled its products in February.See details»


covid-19-rapid-diagnostic-test-market-demand-for-health-supplement-to-boost-growth-by-2028-abbott-laboratories-acon-image

COVID-19 Rapid Diagnostic Test Market: Demand For Health Supplement To Boost Growth By 2028 | Abbott Laboratories, Acon,

Source from : Middle East North Africa Financial Network - 1 days ago

COVID-19 Rapid Diagnostic Test Market COVID-19 infection is caused by the novel SARS-CoV-2, which is a member of single stranded RNA coro ...See details»


what-6-analyst-ratings-have-to-say-about-abbott-laboratories-image

What 6 Analyst Ratings Have To Say About Abbott Laboratories

Source from : Business Insider - 13 days ago

Abbott Laboratories (NYSE: ABT) has observed the following analyst ratings within the last quarter: In the last 3 months, 6 analysts have offered 12-month price targets for Abbott Laboratories. The ...See details»


when-abbott-laboratories-abt-moves-investors-should-listen-image

When Abbott Laboratories (ABT) Moves Investors should Listen

Source from : news.stocktradersdaily - 4 days ago

When Abbott Laboratories ABT Moves Investors should Listen ...See details»


abbott-labs-formula-woes-spell-opportunity-for-rivals-image

Abbott Labs' formula woes spell opportunity for rivals

Source from : Crain's Chicago Business - 9 days ago

Abbott Laboratories is losing its lead in the U.S. baby formula market as the shutdown of an important manufacturing plant drags on. Contamination concerns forced the North Chicago-based company to ...See details»


Abbott Laboratories (ABT): Worth Noting At $107.86

Source from : stocksregister - 7 days ago

Abbott Laboratories (NYSE:ABT) at last check was buoying at $107.86 on Thursday, June 30, with a fall of -1.14% from its closing price on previous day. Taking a look at stock we notice that its last ...See details»


Abbott Laboratories Produced Solid Development In Q1 Notwithstanding A Huge Drop In Nourishing Income

Source from : Middle East North Africa Financial Network - 3 days ago

ABT is a top medical care stock that has been in the news as of late for its part in the U.S. child equation deficiency. It's ...See details»


abbott-finds-support-around-100-image

Abbott Finds Support Around $100

Source from : Seeking Alpha - 7 days ago

Abbott seemed to bounce off of the $100 per share price on the last leg down, and that may end up being extreme support in the near term. It has been a tough year for a great many equities, including ...See details»


Top Stock Reports for Abbott Laboratories, T-Mobile & Intuit

Source from : Nasdaq - 5 days ago

Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), T-Mobile US, Inc. (TMUS) and Intuit Inc. (INTU). These research reports have been ...See details»


has-abbott-labs-declined-to-an-attractive-level-image

Has Abbott Labs Declined to an Attractive Level?

Source from : TheStreet.com - 13 days ago

Abbott Laboratories ( ABT) has been under selling pressure from late December before the shut down and negative publicity surrounding the baby formula shortage. Has the decline from late December to ...See details»


FDA investigating a tenth infant who died after consuming Abbott Labs baby formula product

Source from : World Socialist Web Site - 13 days ago

The FDA reported Wednesday that the baby died in January, a consumer complaint was filed in February but the agency only became aware of the complaint on June 10.See details»